Teva Pharmaceutical Industries Ltd

TEVA

Company Profile

  • Business description

    Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

  • Contact

    124 Dvora HaNevi’a Street
    Tel Aviv6944020
    ISR

    T: +972 39148213

    E: [email protected]

    https://www.tevapharm.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    35,686

Teva Pharmaceutical Industries Ltd News & Analysis

stocks

4 stocks in Buffett's portfolio

These undervalued stocks are among the holdings in Berkshire Hathaway today.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,028.80106.801.20%
CAC 407,621.0410.97-0.14%
DAX 4023,846.0788.380.37%
Dow JONES (US)44,111.7461.90-0.14%
FTSE 1009,142.7314.430.16%
HKSE24,902.53169.080.68%
NASDAQ20,916.55137.03-0.65%
Nikkei 22540,549.54258.840.64%
NZX 50 Index12,853.5823.46-0.18%
S&P 5006,299.1930.75-0.49%
S&P/ASX 2008,770.40106.701.23%
SSE Composite Index3,617.6034.290.96%

Market Movers